Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34482528)
Watch
English
Trelagliptin: First Global Approval
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Trelagliptin: First Global Approval
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
author
Kate McKeage
series ordinal
1
object named as
Kate McKeage
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
publication date
1 July 2015
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
published in
Drugs
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
volume
75
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
issue
10
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
page(s)
1161-1164
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
exact match
https://scigraph.springernature.com/pub.10.1007/s40265-015-0431-9
0 references
cites work
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS40265-015-0431-9
retrieved
21 January 2018
A systematic review of adherence with medications for diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS40265-015-0431-9
retrieved
21 January 2018
The relation between intermittent dosing and adherence: preliminary insights
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS40265-015-0431-9
retrieved
21 January 2018
The role of gut hormones in glucose homeostasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS40265-015-0431-9
retrieved
21 January 2018
Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS40265-015-0431-9
retrieved
21 January 2018
SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS40265-015-0431-9
retrieved
21 January 2018
Identifiers
DOI
10.1007/S40265-015-0431-9
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
Dimensions Publication ID
1045938068
0 references
PubMed ID
26115728
1 reference
stated in
Europe PubMed Central
PubMed ID
26115728
retrieved
2 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
